Elective splenectomy for hematological diseases: a vanishing indication

被引:1
|
作者
Fernandez-Ananin, Sonia [1 ,2 ]
Novelli, Silvana [3 ]
Cabre, Lorena Cambeiro [1 ]
Riera, Cecilia Vila [1 ]
Vazquez, Eulalia Ballester [1 ]
Verdaguer, Elisabet Julia [1 ]
Targarona, Eduardo M. [1 ]
机构
[1] Univ Autonoma Barcelona UAB, Hosp Santa Creu i St Pau, Dept Gen & Digest Surg, Med Sch,Upper Gastrointestinal & Bariatr Surg Unit, St Quinti 89, Barcelona 08041, Spain
[2] Inst Recerca St Pau IR St Pau, Surg Res, Barcelona, Spain
[3] Univ Autonoma Barcelona UAB, Hosp Santa Creu i St Pau, Med Sch, Hematol Dept, Barcelona, Spain
关键词
Laparoscopic splenectomy; Hematological diseases; Autoimmune diseases; Medical therapies; Immune thrombocytopenic purpura; SPLEEN;
D O I
10.1007/s00464-024-11071-8
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction Splenectomy has been used as a diagnostic and therapeutic tool in the management of hematological diseases for many years. However, the emergence of new medical therapies has modified guidelines for many hematological diseases for which splenectomy was previously considered. We aimed to evaluate the evidence of a decrease in the hematological indications for splenectomy and the reasons and justifications for this change. Material and methods We conducted a single-center, retrospective analysis of patients who underwent laparoscopic splenectomy for hematological disease between January 2010 and December 2023. Patients were classified into four groups: 1 autoimmune and hemolytic diseases (HAD), (2) lymphomas, (3) myeloproliferative diseases (MPN), and (4) other splenic diseases. We recorded the annual incidence of splenectomy and the ratio of new medical cases, demographic and clinical data and surgical outcomes. Results During the study period, 98 patients were referred for splenectomy. There was a significant progressive decrease in this surgical indication, particularly regarding HAD (p < 0.001). The indication for splenectomy for immune thrombocytopenic purpura (ITP) declined to zero despite an increase in the number of patients diagnosed with this disorder (p < 0.001). The pattern of decrease in AHAI and Evans syndrome was similar to that in ITP. The group of splenectomies due to lymphoma persisted consistently during the study period, as did the indication for splenectomy in the context of lymphoma treatment. Splenectomy due to massive splenomegaly secondary to MPN was indicated only in one patient. Splenectomies due to other causes were similarly distributed over the years. Conclusions Our findings confirm a significant decrease in the indication for elective surgery for hematological diseases, mainly regarding autoimmune disease. The surgical community and surgical departments should be aware of this situation yet maintain the skills to adopt this technique both safely and efficiently.
引用
收藏
页码:6332 / 6337
页数:6
相关论文
共 50 条
  • [21] Laparoscopic splenectomy for massive splenomegaly in benign hematological diseases
    Al-Mulhim, Abdulrahman Saleh
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2012, 26 (11): : 3186 - 3189
  • [22] Choice of splenectomy method in patients with hematological diseases.
    Karagyulyan, S. R.
    Grzhimolovsky, A. V.
    Danishyan, K. L.
    Shavlokhov, V. S.
    Zakharov, G. N.
    Shutov, S. A.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2007, 52 (01): : 3 - +
  • [23] Laparoscopic splenectomy versus conventional splenectomy in hematological diseases: A thirteen-years experience
    Akyildiz, Hizir
    Akcan, Alper
    Dal, Fatih
    Artis, Tarik
    Kucuk, Can
    Ok, Engin
    Sozuer, Erdogan M.
    TURKISH JOURNAL OF SURGERY, 2007, 23 (01) : 24 - 27
  • [24] Challenges and Results of Laparoscopic Splenectomy for Hematological Diseases in a Developing Country
    Shakya, Vikal Chandra
    Byanjankar, Bikram
    Pandit, Rabin
    Pangeni, Anang
    Shrestha, Anir Ram Moh
    Poudyal, Bishesh
    MINIMALLY INVASIVE SURGERY, 2018, 2018
  • [25] Elective Splenectomy for Hematologic Diseases Can We Predict Complications?
    Arcelus, Juan I.
    JAMA SURGERY, 2014, 149 (10) : 1030 - 1030
  • [26] RESULTS AND COMPLICATIONS FOLLOWING SPLENECTOMY IN PATIENTS WITH HEMATOLOGICAL DISEASES AND CONSIDERABLE SPLENOMEGALY
    HELWEG, J
    EGELUNDCHRISTENSEN, B
    FRIMODTMOLLER, C
    KULDHANSEN, L
    DANISH MEDICAL BULLETIN, 1976, 23 (04): : 205 - 205
  • [27] COMPLICATIONS AND MORTALITY OF EXPLORATORY LAPAROTOMY AND SPLENECTOMY IN LYMPHOGRANULOMATOSIS AND OTHER HEMATOLOGICAL DISEASES
    SEUFERT, RM
    SILBER, R
    ENCKE, A
    BOTTCHER, W
    MITROU, P
    FISCHER, M
    BLUT, 1980, 41 (04): : 312 - 312
  • [28] SPLENECTOMY IN SYSTEMIC LUPUS ERYTHEMATOSUS VERSUS AUTOIMMUNE HEMATOLOGICAL DISEASES: TO LATE OR TO EARLY?
    Barron, G. N.
    Arenas-Osuna, J.
    Velazquez-Garcia, A.
    Gonzalez-Zuniga, A.
    Saavedra, M. A.
    Cruz-Dominguez, P.
    Medina, G.
    Jara, L. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1075 - 1075
  • [29] Laparoscopic splenectomy in the management of hematological diseases - Surgical technique and outcome of 17 patients
    Terrosu, G
    Donini, A
    Silvestri, F
    Petri, R
    Anania, G
    Barillari, G
    Baccarani, U
    Risaliti, A
    Bresadola, F
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 1996, 10 (04): : 441 - 444
  • [30] Splenectomy in Systemic LUPUS Erythematosus and AUTOIMMUNE Hematological Diseases. a Comparative Analysis
    Jara, Luis J.
    Barron, Nahim
    Arenas-Osuna, Jesus
    Velazquez-Garcia, Arturo
    Gonzalez-Zuniga, Arturo
    Saavedra, Miguel A.
    Cruz-Dominguez, Pilar
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S310 - S310